-
Something wrong with this record ?
Cervical cancer screening programmes : managerial guidelines
A.B. MILLER
- Published
- Geneva : WHO, 1992
- Pagination
- 50 s. : obr., tab., bibliogr.
Language English Country Switzerland
Knihovny.cz ISBN
92-4-154447-3
- Keywords
- nádory cervikální, prevence, kontrola, vyšetření hromadná, organizace, národní programy, péče zdravotní primární, gynekologie, ústrojí pohlavní ženské - krček děložní - rakovina - metody vyšetřovací - příručky WHO, krček děložní - rakovina - metody vyšetřovací - prevence - příručky WHO,
- Conspectus
- Lékařské vědy. Lékařství
- NML Fields
- gynekologie a porodnictví
- onkologie
- chemie, klinická chemie
- gynekologie a porodnictví
- NML Publication type
- publikace WHO
A detailed guide to the many factors that need to be considered when planning and managing a screening programme for the early detection of cervical cancer. Noting that screening programmes often fail to have an ipact on incidence rates and mortality, the book concentrates on key managerial decisions, such as the definition of target groups and the frequency of screening, that will determine a programmes capacity to detect cervical cancer at an early, curable stage in the population at greatest risk. Advice and recommendations draw upon evidence from several large investigations as well as experiences with different programmes throughout the world. Policies that consume resources without improving results are clearly indicated. The book has six chapters. The first explains the importance of establishing cervical cancer screening programmes within the context of a national programme for cancer control. Four basic steps in the formulation of a national cancer control policy are identified and discussed as they relate to requirements for the control of cervical cancer. The chapter also describes several simple methods that can be used to gather data and support well-informed decisions. The second chapter reviews current knowledge about the natural history of cervical cancer in terms of its implications for screening policy. Readers are informed that the most important risk factor is age, that programmes should concentrate on women aged 35 years and older, that screening of younger women can lead to useless overtreatment, and that annual screening is totally unnecessary. The third chapter sets out managerial guidelines for the implementation and evaluation of screening programmes. Concentrating on key managerial decisions, the chapter considers such questions as when a screening programme can be implemented, which sector of the health service should be used as the organizational base, and who should be responsible for management, surveillance, and evaluation. Concerning selection of the most appropriate service sector, the chapter considers the pros and cons of using maternal, child health and family planning services, occupational health services, and mobile screening units. Other chapters offer advice on the organization of screening programmes in the context of primary health care, and outline programme requirements in terms of information systems. The final chapter presents the concept of downstaging as an interim measure that might reduce mortality from cervical cancer in countries lacking the facilities and resources required for population-wide screening. Noting the high proportion of cases diagnosed at an advanced stage in these countries, the chapter explains how downstaging, which involves the use of a simple speculum for visual inspection of the cervix, might result in detection of cervical cancer at an earlier stage when treatment is still possible
Owner | Details | Services |
---|---|---|
NLK | NLK Shelf no. K 62641 [0] | ... |
NLK-OVI MZ ČR | NLK-OVI MZ ČR Shelf no. K 109/1992/A 270 [0] | ... |
- 000
- 01263nam 2200349 a 4500
- 001
- MED00030612
- 003
- CZ-PrNML
- 005
- 20141219122317.0
- 008
- 930224s1992 sz eng||
- 009
- BK
- 020 __
- $a 92-4-154447-3
- 040 __
- $a ABA008 $b cze $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz $c CH
- 072 _7
- $x Lékařské vědy. Lékařství $a 61 $2 konspekt $7 sk136310
- 080 __
- $a 616-006 $2 h
- 080 __
- $a 616-07 $2 h
- 080 __
- $a 618 $2 h
- 100 1_
- $a Miller, A. B. $4 aut $7 _gn020028301
- 245 10
- $a Cervical cancer screening programmes : $b managerial guidelines / $c A.B. MILLER
- 260 __
- $a Geneva : $b WHO, $c 1992
- 300 __
- $a 50 s. : $b obr., tab., bibliogr.
- 650 07
- $a gynekologie a porodnictví $2 mednas $7 nlk20040147647
- 650 07
- $a onkologie $2 mednas $7 nlk20040148136
- 650 07
- $a chemie, klinická chemie $2 mednas $7 nlk20040147810
- 650 07
- $a gynekologie a porodnictví $2 mednas $7 nlk20040147647
- 653 _3
- $a nádory cervikální
- 653 _3
- $a prevence
- 653 _3
- $a kontrola
- 653 _3
- $a vyšetření hromadná
- 653 _3
- $a organizace
- 653 _3
- $a národní programy
- 653 _3
- $a péče zdravotní primární
- 653 _3
- $a gynekologie
- 653 _0
- $a ústrojí pohlavní ženské - krček děložní - rakovina - metody vyšetřovací - příručky WHO
- 653 _0
- $a krček děložní - rakovina - metody vyšetřovací - prevence - příručky WHO
- 655 _4
- $a publikace WHO $7 nlk20040156070
- 910 __
- $a ABA008 $b K 62641 $y §
- 910 __
- $a ABE015 $b K 109/1992/A 270 $y 0
- 990 __
- $a 19970421 $b ABA008
- 991 __
- $a 20040927 $b ABA008
- BAS __
- $a NML $a 02 $a 11 $a 20 $a 49